propharma

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark propharma was filed as Figurative mark on 12/20/2022 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Letters presenting a special form of writing #Series of letters presenting different forms of writing

Trademark Details Last update: April 12, 2023

Trademark form Figurative mark
File reference 1720479
Countries Brazil Canada Switzerland China Germany em India Mexico New Zealand
Base trademark US No. 97718561, December 15, 2022
Application date December 20, 2022
Expiration date December 20, 2032

Trademark owner

8717 W 110th Street, Suite 300
Overland Park KS 66210
US

Trademark representatives

10801 Mastin St., Suite 1000 Overland Park KS 66210 US

goods and services

35 Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files
42 Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes
44 Consulting services in the medical, pharmaceutical, and biotechnology fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status
45 Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; regulatory compliance consulting in the fields of drug and device development and manufacturing; tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes

Trademark history

Date Document number Area Entry
April 10, 2023 2023/15 Gaz IN Rejection
April 5, 2023 2023/14 Gaz NZ Rejection
December 20, 2022 2023/10 Gaz US Registration

ID: 141720479